MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study
(Adnkronos) – GENEVA, Sept. 15, 2023 /PRNewswire/ — MedAlliance has announced enrollment of over 1,660 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now half way towards a planned
